Chronic Kidney Disease News and Research

Latest Chronic Kidney Disease News and Research

Tracking kidney number is just as important as controlling cholesterol, say DNA physicians

It's a silent epidemic that affects millions of Americans. Chronic Kidney Disease (CKD) is a life-threatening illness that can often be treated successfully if found early, and can be detected at an early stage using simple, inexpensive blood and urine tests. As part of its 2010 World Kidney Day awareness program, the physicians of Dallas Nephrology Associates urge everyone to know and track their "kidney number."

9 Mar 2010

DaVita's presentations at ADC: New developments in the field of CKD, Vascular Access and Home Modalities

DaVita Inc., a leading provider of kidney care services for those diagnosed with chronic kidney disease (CKD), in conjunction with DaVita Clinical Research®, today announced that company representatives will present 20 presentations at the 30th Annual Dialysis Conference scheduled for March 6 – 9 in Seattle.

8 Mar 2010

Dialysis patients gather to encourage state lawmakers to support Medigap legislation

More than 50 dialysis patients, family members and kidney care advocates from across South Carolina gathered at the state Capitol today with the National Kidney Foundation Serving the Carolinas, South Carolina Region (NKF) and Dialysis Patient Citizens (DPC) to encourage state lawmakers to support Medigap legislation (S. 1128, sponsored by Senators Harvey Peeler (R-Cherokee) and Phillip Shoopman (R-Greenville), and H. 4552, sponsored by Representatives Joan Brady (R-Richland), Bill Sandifer (R-Seneca) and Kristopher Crawford (R-Florence)).

5 Mar 2010

2010 Federal Budget lacks substantive funding in support of heart health initiatives: HSF concerned

The Heart and Stroke Foundation (HSF) is concerned with the lack of any substantive funding in support of heart health initiatives as outlined in today's 2010 Federal Budget.

5 Mar 2010

athenahealth, DaVita to deliver web-based EHR and revenue cycle management service to nephrologists

athenahealth, Inc., a leading provider of internet-based business services to physician practices, and DaVita Inc., a leading provider of kidney care services for those diagnosed with chronic kidney disease (CKD), announced a partnership to deliver an integrated, web-based electronic health record (EHR) and revenue cycle management service to nephrologists across the country.

3 Mar 2010

Greater use of ESAs and iron at lower hematocrit levels decrease risk of death for hemodialysis patients

Greater use of erythropoiesis-stimulating agents (ESAs) and more frequent use of iron at lower hematocrit levels (the proportion of the blood that consists of red blood cells) was associated with a decreased risk of death for hemodialysis patients, according to a study in the March 3 issue of JAMA.

3 Mar 2010

Aggressive treatment of anemia with ESAs may lower risk of death for dialysis patients: Study

Aggressive treatment of anemia with intravenous iron and drugs known as erythropoiesis-stimulating agents (ESAs) may lower the risk of death for dialysis patients with severe anemia - but also may increase the risk of death among patients with milder anemia, a new study led by a University of North Carolina at Chapel Hill epidemiologist suggests.

3 Mar 2010

AMAG Pharmaceuticals reports fourth-quarter 2009 net product revenues of $12.8M attributable to Feraheme

AMAG Pharmaceuticals, Inc., a biopharmaceutical company focused on the development and commercialization of a therapeutic iron compound to treat iron deficiency anemia and novel imaging agents to aid in the diagnosis of cancer and cardiovascular disease, today reported unaudited consolidated financial results for the fourth quarter and year ended December 31, 2009.

1 Mar 2010

New genetic data may help predict risk for end-stage kidney disease

Israeli and American researchers have identified new genetic data that could be used in the future to predict who will develop end-stage kidney disease (ESKD). ESKD requires dialysis or transplantation to sustain life, and is fatal in most regions of the world, where these treatments are not available.

24 Feb 2010

AMAG's Feraheme use on the rise

BioTrends Research Group, Inc. released Wave 3 of its LaunchTrends®: Feraheme report, the third in a multi-phase syndicated market research project tracking the launch of AMAG's new IV iron product, Feraheme, through the first six months of product availability. Each wave of the report provides quantitative information from 50 unique Nephrologists and qualitative information from a subset of 15. The reports assess trial and use of Feraheme, obstacles to use, reasons to use, typical patient types, product perceptions, promotional efforts/messages, and product satisfaction.

17 Feb 2010

3SBio submits application for Phase I clinical trial of NuPIAO to the Chinese SFDA

3SBio Inc., a leading biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products primarily in China, today announced that it has submitted its application for a Phase I clinical trial for NuPIAO to the Chinese State Food and Drug Administration (SFDA).

11 Feb 2010

Low potassium levels increase risk of death in patients with heart failure and CKD

New research from the University of Alabama at Birmingham (UAB) says low potassium levels produce an increased risk of death or hospitalization in patients with heart failure and chronic kidney disease (CKD).

10 Feb 2010

Low potassium levels increase risk of death in patients with heart failure and CKD

9 Feb 2010

3SBio announces Nephoxil collaboration and license agreement with Panacor Bioscience

3SBio Inc., a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced a collaboration and license agreement with Panacor Bioscience Ltd. to develop and commercialize its Nephoxil(R) pharmaceutical product for the treatment of hyperphosphatemia in China.

8 Feb 2010

AMAG Pharmaceuticals releases safety update on Feraheme Injection

AMAG Pharmaceuticals, Inc., a biopharmaceutical company focused on the development and commercialization of a therapeutic iron compound to treat anemia and novel imaging agents to aid in the diagnosis of cancer and cardiovascular disease, today provided a safety update on Feraheme® (ferumoxytol) Injection for intravenous use.

6 Feb 2010

Patients with high levels of proteinuria have increased risk of all-cause death

Patients with high levels of proteinuria (protein in urine) in addition to another marker of reduced kidney function had an associated increased risk of all-cause death, heart attack or progression to kidney failure, according to a study in the February 3 issue of JAMA.

3 Feb 2010

DSG’s eCaseLink EDC system employed in clinical trials for treatment of chronic kidney disease

DSG’s eCaseLink™ Electronic Data Capture (EDC) and data management are currently being used by a biotechnology company for two current phase 2 and phase 2a clinical trials for treatments of progressive and chronic kidney disease.

1 Feb 2010

Research shows even mild to moderate kidney disease may diminish child's quality of life

Challenging prevailing wisdom that only children with end-stage kidney disease suffer physical, social, emotional and educational setbacks from their disease, research led by Johns Hopkins Children's Center shows that even mild to moderate kidney disease may seriously diminish a child's quality of life.

28 Jan 2010

Movie star attends RSN Renal Teen Prom

For one precious night, movie star Jack Black helped more than 250 teens forget about dialysis and renal disease and enjoy a right of passage most kids take for granted—the prom.

19 Jan 2010

CKD patients do not receive adequate end-of-life care

Patients with advanced chronic kidney disease (CKD) often do not receive adequate end-of-life care and are unhappy with the medical decisions made as their conditions worsen, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology (CJASN). The findings indicate that end-of-life care should be improved to meet the needs of CKD patients.

18 Jan 2010

Chronic Kidney Disease News and Research

Latest Chronic Kidney Disease News and Research

Tracking kidney number is just as important as controlling cholesterol, say DNA physicians

DaVita's presentations at ADC: New developments in the field of CKD, Vascular Access and Home Modalities

Dialysis patients gather to encourage state lawmakers to support Medigap legislation

2010 Federal Budget lacks substantive funding in support of heart health initiatives: HSF concerned

athenahealth, DaVita to deliver web-based EHR and revenue cycle management service to nephrologists

Greater use of ESAs and iron at lower hematocrit levels decrease risk of death for hemodialysis patients

Aggressive treatment of anemia with ESAs may lower risk of death for dialysis patients: Study

AMAG Pharmaceuticals reports fourth-quarter 2009 net product revenues of $12.8M attributable to Feraheme

New genetic data may help predict risk for end-stage kidney disease

AMAG's Feraheme use on the rise

3SBio submits application for Phase I clinical trial of NuPIAO to the Chinese SFDA

Low potassium levels increase risk of death in patients with heart failure and CKD

Low potassium levels increase risk of death in patients with heart failure and CKD

3SBio announces Nephoxil collaboration and license agreement with Panacor Bioscience

AMAG Pharmaceuticals releases safety update on Feraheme Injection

Patients with high levels of proteinuria have increased risk of all-cause death

DSG’s eCaseLink EDC system employed in clinical trials for treatment of chronic kidney disease

Research shows even mild to moderate kidney disease may diminish child's quality of life

Movie star attends RSN Renal Teen Prom

CKD patients do not receive adequate end-of-life care

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Chronic Kidney Disease News and Research

Latest Chronic Kidney Disease News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in